Not Even a Breakup Can Slow Down This Tiny BiotechBy William Patalon III, Executive Editor, Money Morning • August 4, 2016Start the conversationLeave a Reply Click here to cancel reply.Your email address will not be published. Required fields are marked *Name * Email * Website + three = 8 Comment Some HTML is OK Sign me up for the Money Morning newsletter William Patalon IIIOn Wednesday, Roche Holding Ltd. (OTC ADR: RHHBY) and Inovio Pharmaceuticals Inc. (Nasdaq: INO) announced that the biotech duo are quitting their three-year partnership.The two biotech firms were working together on development of INO-1800 - an immunotherapy molecule targeting prostate cancer and hepatitis B.This is premium content for Private Briefing subscribers only. As the executive editor of Money Morning, Bill Patalon has perfected a secret investment strategy that could help you put an extra $125K into your portfolio - this year. To date, Bill has used this strategy to pick 257 winning investments, including 192 double- and triple-digit peak gains. Once you see the secret, you'll immediately understand why it works so well.